非酒精性脂肪性肝病患者肝纤维化评估中非侵入性方法的应用与局限性
Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
作者信息
Robinson Ann, Wong Robert J
机构信息
Department of Medicine Division of Gastroenterology and Hepatology Alameda Health System-Highland Hospital Oakland CA.
出版信息
Clin Liver Dis (Hoboken). 2020 May 7;15(4):157-161. doi: 10.1002/cld.878. eCollection 2020 Apr.
Abstract
http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-4-reading-robinson a video presentation of this article https://www.wileyhealthlearning.com/Activity/7088585/disclaimerspopup.aspx questions and earn CME.
相似文献
1
Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝纤维化评估中非侵入性方法的应用与局限性
Clin Liver Dis (Hoboken). 2020 May 7;15(4):157-161. doi: 10.1002/cld.878. eCollection 2020 Apr.
2
Managing the Symptoms and Complications of Cholestasis.胆汁淤积症状及并发症的管理
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):120-124. doi: 10.1002/cld.901. eCollection 2020 Mar.
3
Isolated Elevated Bilirubin.孤立性胆红素升高
Clin Liver Dis (Hoboken). 2020 May 7;15(4):153-156. doi: 10.1002/cld.944. eCollection 2020 Apr.
4
The Pathophysiology of Cholestasis and Its Relevance to Clinical Practice.胆汁淤积的病理生理学及其与临床实践的相关性。
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):110-114. doi: 10.1002/cld.894. eCollection 2020 Mar.
5
Novel Therapies for Managing Cholestasis.治疗胆汁淤积的新型疗法
Clin Liver Dis (Hoboken). 2020 Apr 4;15(3):95-99. doi: 10.1002/cld.886. eCollection 2020 Mar.
6
Spotlight on Impactful Research: Long-Term Calcineurin Inhibitor Therapy and Brain Function in Patients After Liver Transplantation.聚焦有影响力的研究：肝移植术后患者长期钙调神经磷酸酶抑制剂治疗与脑功能
Clin Liver Dis (Hoboken). 2020 May 7;15(4):141-143. doi: 10.1002/cld.910. eCollection 2020 Apr.
7
Treating Alcohol Use Disorder in Chronic Liver Disease.治疗慢性肝病中的酒精使用障碍
Clin Liver Dis (Hoboken). 2020 Mar 26;15(2):77-80. doi: 10.1002/cld.881. eCollection 2020 Feb.
8
Nutritional Management of Cholestasis.胆汁淤积的营养管理
Clin Liver Dis (Hoboken). 2020 Feb 25;15(1):9-12. doi: 10.1002/cld.865. eCollection 2020 Jan.
9
Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines.乙型肝炎病毒再激活：临床指南综述
Clin Liver Dis (Hoboken). 2020 May 7;15(4):162-167. doi: 10.1002/cld.883. eCollection 2020 Apr.
10
Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients With Cirrhosis Undergoing Liver Transplant Evaluation.聚焦重大研究：阿司匹林和他汀类药物在接受肝移植评估的肝硬化患者冠状动脉疾病管理中的应用
Clin Liver Dis (Hoboken). 2020 Mar 26;15(2):69-70. doi: 10.1002/cld.899. eCollection 2020 Feb.
引用本文的文献
1
Proof of concept pilot study to assess the utility of magnetic resonance extra-cellular volume quantification to diagnose advanced liver disease in people with Cystic Fibrosis.评估磁共振细胞外容积定量在诊断囊性纤维化患者晚期肝病中的效用的概念验证性初步研究。
PLoS One. 2025 Mar 4;20(3):e0318085. doi: 10.1371/journal.pone.0318085. eCollection 2025.
2
Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study.维生素 D 与 2 型糖尿病研究中糖尿病前期的肝脂肪变性和纤维化指标及其与糖尿病发展的关系。
J Diabetes Complications. 2023 Jun;37(6):108475. doi: 10.1016/j.jdiacomp.2023.108475. Epub 2023 Apr 12.
3
Diagnostic Performance of Acoustic Radiation Force Impulse Imaging in Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Infection: A Cross-Sectional Study.声辐射力脉冲成像在评估慢性乙型肝炎感染患者肝纤维化中的诊断性能：一项横断面研究
Indian J Radiol Imaging. 2022 Aug 30;32(3):287-293. doi: 10.1055/s-0042-1755251. eCollection 2022 Sep.
本文引用的文献
1
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
2
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis.ADAPT：一种纳入 PRO-C3 的算法可准确识别非酒精性脂肪性肝病伴进展性肝纤维化患者。
Hepatology. 2019 Mar;69(3):1075-1086. doi: 10.1002/hep.30163.
3
Noninvasive biomarkers in NAFLD and NASH - current progress and future promise.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的无创性生物标志物：当前进展与未来前景。
Nat Rev Gastroenterol Hepatol. 2018 Aug;15(8):461-478. doi: 10.1038/s41575-018-0014-9.
4
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease.用于评估非酒精性脂肪性肝病的振动控制瞬时弹性成像的性能特征
Hepatology. 2018 Jan;67(1):134-144. doi: 10.1002/hep.29489. Epub 2017 Nov 29.
5
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
6
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.比较实验室检查、超声或磁共振弹性成像在非酒精性脂肪性肝病患者中检测纤维化的价值：一项荟萃分析。
Hepatology. 2017 Nov;66(5):1486-1501. doi: 10.1002/hep.29302. Epub 2017 Sep 26.
7
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.基于肠道微生物群的宏基因组特征用于非侵入性检测人类非酒精性脂肪性肝病中的晚期纤维化
Cell Metab. 2017 May 2;25(5):1054-1062.e5. doi: 10.1016/j.cmet.2017.04.001.
8
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.非酒精性脂肪性肝病中纤维化阶段导致的死亡风险增加：系统评价与荟萃分析
Hepatology. 2017 May;65(5):1557-1565. doi: 10.1002/hep.29085. Epub 2017 Mar 31.
9
Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.联合FibroMeter振动控制瞬时弹性成像算法在中国非酒精性脂肪性肝病患者中的应用
J Gastroenterol Hepatol. 2017 Jul;32(7):1363-1369. doi: 10.1111/jgh.13671.
10
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.年龄作为晚期非酒精性脂肪性肝病纤维化准确无创诊断的混杂因素。
Am J Gastroenterol. 2017 May;112(5):740-751. doi: 10.1038/ajg.2016.453. Epub 2016 Oct 11.
Zotero 插件